The two-year programme will use virtual reality technology to teach essential skills
Category: News
The London hub is home to life sciences companies including Novartis, Engitix and invoX Pharma
There are around 55,100 new prostate cancer cases in the UK every year
Study reveals potential new strategy for managing inflammatory bowel disease
Partnership to harness AI for DUB-focused preclinical programmes
Acquisition to enhance Lundbeck’s neuroscience pipeline
Phase 2 study of TG4001 shows promise in cervical cancer patients
Sheffield cardiologists demonstrate cutting-edge TAVI procedure
Teclistamab offers hope for patients exhausting treatment options
New investment to advance gene therapies for kidney diseases